Skip to main content
. 2023 Jan 24;15(2):322. doi: 10.3390/v15020322

Figure 1.

Figure 1

Difference between baseline absolute CD4+ lymphocytes (cells/mm3), baseline absolute CD8+ lymphocytes (cells/mm3), and baseline CD4/CD8 ratio of HIV-positive patients at 24, 48, and 96 weeks of DTG plus 3TC treatment. Panel (A): Gender differences; Panel (B): Differences between patients with and without comorbidities; Panel (C): Differences in patients with and without AIDS. Significant values: p-value < 0.05 = *; p-value < 0.01 = **.